Hypertension, Pulmonary - 26 Studies Found
| Recruiting |
: Acute Hemodynamic Effect of Acetazolamide in Pulmonary Hypertension : Hypertension, Pulmonary : 2016-03-24 :
|
| Recruiting |
: EXPERT, EXPosurE Registry RiociguaT in Patients With Pulmonary Hypertension : Hypertension, Pulmonary : 2014-03-19 : Drug: Riociguat(BAY63-2521) The decision on clinical management of the patient including the actual trea |
| Recruiting |
: Prospective, Non-interventional, Multi-center Post-authorization Safety Study of Riociguat for Chronic Thromboembolic Pulmonary Hypertension (CTEPH ) : Hypertension, Pulmonary : 2014-04-16 : Drug: Riociguat (ADEMPAS, BAY63-2521) The treatment of Riociguat should comply with the local product in |
| Active, not recruiting |
: Impact of Multiple Doses of BAY63-2521 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Patients With Interstitial Lung Disease (ILD) Associated Pulmonary Hypertension (PH) : Hypertension, Pulmonary : 2008-06-09 : Drug: Riociguat (Adempas, BAY63-2521) BAY63-2521 will be up-titrated from 1,0 mg TID to 2,5 mg TID |
| Completed |
: Safety Follow-up Study of Inhaled Iloprost in Patients With Pulmonary Hypertension : Hypertension, Pulmonary : 2005-09-13 : Drug: Ventavis (Iloprost, BAYQ6256) Inhaled iloprost |
| Terminated |
: Safety of Terbogrel in Patients With Primary Pulmonary Hypertension : Hypertension, Pulmonary : 2014-08-21 : Drug: Terbogrel |
| Completed |
: Safety and Efficacy of Terbogrel in Patients With Primary Pulmonary Hypertension : Hypertension, Pulmonary : 2014-08-21 :
|
| Completed |
: Interaction Study in Patients With Pulmonary Hypertension and Stable Treatment of Sildenafil 20 mg TID : Hypertension, Pulmonary : 2008-05-16 : Drug: Riociguat (Adempas, BAY63-2521) The investigational drug will be given twice per subject, as singl |
| No longer available |
: Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH) : Hypertension, Pulmonary : 2013-02-04 : Drug: Adempas (Riociguat, BAY63-2521) Individual dosing of riociguat between 0.5 and 2.5 mg three times |
| Terminated |
: Inhaled Aerosolized Prostacyclin for Pulmonary Hypertension Requiring Inhaled Nitric Oxide : Pulmonary Hypertension : 2014-06-19 : Drug: Inhaled Iloprost A 20 mcg dose of Iloprost will be given initially. |